Elaris FlexCo signs global licence agreement with Valneva
Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars
Sanofi's venglustat receives FDA Breakthrough Therapy designation for type 3 Gaucher disease
Avacta opens Phase 1 trial for AVA6103 cancer therapy in US
Imfinzi approved in EU for perioperative treatment of early gastric and gastroesophageal cancers
26Health acquires Optimal Integrative Care
Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China
Aditxt acquires Ignite Proteomics to enhance cancer therapy selection
Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004
Andel launches new direct-to-employer medication platform for GLP-1s
Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial
NASA awards Redwire USD4m to advance drug development in microgravity
Elicera Therapeutics receives Japanese patent allowance for ELC-401 CAR T-cell candidate